Articles by James P. Agalloco - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by James P. Agalloco

Overcoming Limitations of Vaporized Hydrogen Peroxide

Vaporous hydrogen peroxide, used for sterilization and decontamination, is highly potent but presents implementation challenges.
Sep 2, 2013

Vaporous hydrogen peroxide, used for sterilization and decontamination, is highly potent but presents implementation challenges.

A More Rational Approach for Sterile Product Manufacturing

The authors assert that the current gulf between aseptic processing and terminal sterilization can be bridged by re-examining fundamental regulatory philosophies for sterile-product manufacturing.
May 1, 2012

The authors assert that the current gulf between aseptic processing and terminal sterilization can be bridged by re-examining fundamental regulatory philosophies for sterile-product manufacturing.

Regulation of Aseptic Processing in the 21st Century

The authors question certain aspects of the industry's current regulatory-compliance strategy and suggest that aseptic-process control and evaluation should be revised.
May 1, 2011

The authors question certain aspects of the industry's current regulatory-compliance strategy and suggest that aseptic-process control and evaluation should be revised.

Revisiting Interventions in Aseptic Processing

The authors revisit their previous effort to refine the terms that describe interventions and to dispel confusion that arose after the original article was published.
Apr 2, 2011

The authors revisit their previous effort to refine the terms that describe interventions and to dispel confusion that arose after the original article was published.

Risk-Based Thinking in Process Validation

The author describes why statistical significance would impose an unreasonable burden on manufacturers.
Feb 2, 2011

The author describes why statistical significance would impose an unreasonable burden on manufacturers.

The Importance of Equivalence in the Execution and Maintenance of Validation Activities

The author explains the idea of equivalence and describes how it can facilitate equipment validation.
Dec 2, 2010

The author explains the idea of equivalence and describes how it can facilitate equipment validation.

The Myth Called "Sterility"

The authors propose a process-centric approach for carrying out aseptic-processing and suggest further dialogue. This articles contains bonus online-exclusive material.
Mar 1, 2010

The authors propose a process-centric approach for carrying out aseptic-processing and suggest further dialogue. This articles contains bonus online-exclusive material.

FDA's Draft Guidance for Process Validation: Can It Be Applied Universally?

The author describes various manufacturing processes and evaluates whether the guidance can be applied to each of them.
May 1, 2009

The author describes various manufacturing processes and evaluates whether the guidance can be applied to each of them.

Compliance Risk Management Using a Top-Down Validation Approach

Patient safety must be the primary concern of any validation effort. The author explains how a risk-based approach to validation and compliance follows naturally from this premise.
Jul 2, 2008

Patient safety must be the primary concern of any validation effort. The author explains how a risk-based approach to validation and compliance follows naturally from this premise.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here